Craniopharyngioma: presentation and endocrine sequelae in 36 children
- PMID: 12880119
- DOI: 10.1515/jpem.2003.16.5.703
Craniopharyngioma: presentation and endocrine sequelae in 36 children
Abstract
We studied the clinical presentation by age of 36 children with craniopharyngioma, and outcome by height and body mass index (BMI). Presenting symptoms included headache (51.4%), vomiting (31%), visual disturbances (22.9%), polyuria and/or polydipsia (17.1%), delayed puberty (19.4%), short stature (13.8%), and precocious puberty (2.7%). Growth deceleration was overlooked, as was diabetes insipidus (actual rate, 52% for both). Delayed puberty was observed in all patients of appropriate age. Mean height standard deviation score (SDS) at admission was significantly lower than mean target height SDS (p = 0.004), while mean final height SDS was similar (p = 0.14). BMI SDS at last follow-up was similar to mean parental BMI SDS. We conclude that although endocrinopathies are present in most patients with craniopharyngioma, they are rarely the reason for referral. While affected prepubertal children have non-endocrine complaints, most adolescents are referred because of delayed puberty. Diabetes insipidus may be more prevalent in craniopharyngioma than previously reported. When patients with hypothalamic obesity are excluded, mean BMI SDS remains within normal range and is influenced mostly by parental BMI SDS.
Similar articles
-
Craniopharyngioma presenting as precocious puberty and accelerated growth.Clin Pediatr (Phila). 2003 Mar;42(2):181-4. doi: 10.1177/000992280304200213. Clin Pediatr (Phila). 2003. PMID: 12659393 No abstract available.
-
Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.J Endocrinol Invest. 2021 Nov;44(11):2367-2374. doi: 10.1007/s40618-021-01541-4. Epub 2021 Mar 8. J Endocrinol Invest. 2021. PMID: 33683662
-
Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:431-7. J Pediatr Endocrinol Metab. 2006. PMID: 16700321
-
Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children.Pediatr Endocrinol Rev. 2017 Mar;14(3):298-301. Pediatr Endocrinol Rev. 2017. PMID: 28508600 Review.
-
The pre-operative endocrine assessment of craniopharyngiomas.J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:325-7. J Pediatr Endocrinol Metab. 2006. PMID: 16700307 Review.
Cited by
-
Endocrine manifestations of craniopharyngioma.Childs Nerv Syst. 2005 Aug;21(8-9):640-8. doi: 10.1007/s00381-005-1246-x. Epub 2005 Jul 27. Childs Nerv Syst. 2005. PMID: 16047216 Review.
-
Epidemiology of craniopharyngiomas: a population-based study in Malta.Endocr Oncol. 2021 May 28;1(1):9-16. doi: 10.1530/EO-21-0006. eCollection 2021 Jan. Endocr Oncol. 2021. PMID: 37435184 Free PMC article.
-
Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.Childs Nerv Syst. 2005 Aug;21(8-9):747-57. doi: 10.1007/s00381-005-1186-5. Epub 2005 Jul 2. Childs Nerv Syst. 2005. PMID: 15995885 Clinical Trial.
-
Recurrent Urinary Tract Infection in Craniopharyngioma: A Harbinger to a Sinister Diagnosis!J Pediatr Neurosci. 2020 Jul-Sep;15(3):308-310. doi: 10.4103/jpn.JPN_20_20. Epub 2020 Nov 6. J Pediatr Neurosci. 2020. PMID: 33531954 Free PMC article.
-
Visual functions in children with craniopharyngioma at diagnosis: A systematic review.PLoS One. 2020 Oct 1;15(10):e0240016. doi: 10.1371/journal.pone.0240016. eCollection 2020. PLoS One. 2020. PMID: 33002047 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical